Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor
Interventions: DRUG: CPO-100
Sponsor: Conjupro Biotherapeutics, Inc.
Collaborators: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.